A phase I/II trial of docetaxel (D) and oxaliplatin (O) in patients with advanced gastric cancer (AGC)

被引：0
|
作者：
Park, Y. [1 ]
Kim, K. [1 ]
Choi, M. [1 ]
Hong, J. [1 ]
Lee, E. [1 ]
Park, M. [1 ]
Kim, H. [1 ]
Lee, Y. [1 ]
Park, J. [1 ]
Lim, H. [1 ]
Kang, W. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15615
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Zang, Dae Young
    Yang, Dae Hyun
    Lee, Hae Wan
    Hwang, Se Won
    Song, Hun Ho
    Jung, Joo Young
    Kwon, Jung Hye
    Kim, Hyo Jung
    Kim, Jung Han
    Park, Sa Rah
    Kim, Min-Jeong
    Jang, Kyung Mi
    Park, Choong Kee
    Kim, Jong Hyeok
    Lee, Bong Hwa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 509 - 516
  • [32] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Dae Young Zang
    Dae Hyun Yang
    Hae Wan Lee
    Se Won Hwang
    Hun Ho Song
    Joo Young Jung
    Jung Hye Kwon
    Hyo Jung Kim
    Jung Han Kim
    Sa Rah Park
    Min-Jeong Kim
    Kyung Mi Jang
    Choong Kee Park
    Jong Hyeok Kim
    Bong Hwa Lee
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 509 - 516
  • [33] A phase I trial of docetaxel and gemcitabine in patients with advanced cancer
    Rischin, D
    Boyer, M
    Smith, J
    Millward, M
    Michael, M
    Bishop, J
    Zalcberg, J
    Davison, J
    Emmett, E
    McClure, B
    ANNALS OF ONCOLOGY, 2000, 11 (04) : 421 - 426
  • [34] Oxaliplatin and Irinotecan in advanced gastric cancer.: A multicenter phase II trial
    Woell, E.
    Eisterer, W.
    Hilbe, W.
    Kuehr, T.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Baldinger, C.
    Thaler, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [35] Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study
    Soh Saitoh
    Yuh Sakata
    Gastric Cancer, 2002, 5 (Suppl 1) : 23 - 26
  • [36] Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer
    K Yamaguchi
    T Shimamura
    I Hyodo
    W Koizumi
    T Doi
    H Narahara
    Y Komatsu
    T Kato
    S Saitoh
    T Akiya
    M Munakata
    Y Miyata
    Y Maeda
    H Takiuchi
    S Nakano
    T Esaki
    F Kinjo
    Y Sakata
    British Journal of Cancer, 2006, 94 : 1803 - 1808
  • [37] Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: A multicenter phase I/II study
    Mitachi Y.
    Sakata Y.
    Ohtsu A.
    Hyodo I.
    Katsu K.
    Sairenji M.
    Saitoh S.
    Suwa T.
    Sato T.
    Miyata Y.
    Gastric Cancer, 2002, 5 (3) : 160 - 167
  • [38] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
    Sym, S.
    Park, S.
    Park, J.
    Kwon, K.
    Jung, I.
    Cho, E.
    Lee, W.
    Chung, M.
    Shin, D.
    Lee, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
    Sym, S.
    Park, S.
    Park, J.
    Park, Y.
    Jung, I.
    Cho, E.
    Lee, W.
    Chung, M.
    Shin, D.
    Lee, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 383 - 383
  • [40] Phase II study of docetaxel, cisplatin and modulated oral tegafur (DCT) in advanced gastric cancer (AGC)
    Pericay, Carles
    Losa, Ferran
    Nogue, Miquel
    Gallardo, Enrique
    Fernandez-Morales, Luis
    Dalmau, Elsa
    Martinez-Peralta, Susana
    Santos-Vivas, Cristina
    Pous, Enric
    Saigi, Eugeni
    ANNALS OF ONCOLOGY, 2006, 17 : 324 - 324
12345